SE420602B - Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat - Google Patents

Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat

Info

Publication number
SE420602B
SE420602B SE7416137A SE7416137A SE420602B SE 420602 B SE420602 B SE 420602B SE 7416137 A SE7416137 A SE 7416137A SE 7416137 A SE7416137 A SE 7416137A SE 420602 B SE420602 B SE 420602B
Authority
SE
Sweden
Prior art keywords
metoxi
carboxamide derivatives
pyrazine
prepare
prepare pyrazine
Prior art date
Application number
SE7416137A
Other languages
English (en)
Swedish (sv)
Other versions
SE7416137L (xx
Inventor
M Murakami
K Takahashi
Y Hirata
M Takashima
M Takeda
H Ino
S Iwanami
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49007726A external-priority patent/JPS50105675A/ja
Priority claimed from JP4302774A external-priority patent/JPS50140468A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of SE7416137L publication Critical patent/SE7416137L/xx
Publication of SE420602B publication Critical patent/SE420602B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
SE7416137A 1974-01-16 1974-12-20 Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat SE420602B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP49007726A JPS50105675A (en) 1974-01-16 1974-01-16 Pirajinjudotai no seiho
JP4302774A JPS50140468A (xx) 1974-04-16 1974-04-16

Publications (2)

Publication Number Publication Date
SE7416137L SE7416137L (xx) 1975-07-17
SE420602B true SE420602B (sv) 1981-10-19

Family

ID=26342070

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7416137A SE420602B (sv) 1974-01-16 1974-12-20 Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat

Country Status (11)

Country Link
US (1) US4041032A (xx)
AT (1) AT340437B (xx)
CA (1) CA1050540A (xx)
DE (1) DE2461802C2 (xx)
DK (1) DK139846B (xx)
ES (1) ES433462A1 (xx)
FR (1) FR2257293B1 (xx)
GB (1) GB1484049A (xx)
NL (1) NL7417060A (xx)
SE (1) SE420602B (xx)
YU (1) YU36934B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE845612A (fr) * 1976-03-23 1977-02-28 Derives de tetrazole-5-carboxamide et leur preparation
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
US4803206A (en) * 1988-03-07 1989-02-07 Schering Corporation Antihypertensive acylpyrazines
JP2599665B2 (ja) * 1991-05-01 1997-04-09 大塚製薬株式会社 ピラジン誘導体
FR2705344B1 (fr) * 1993-05-17 1995-06-30 Synthelabo Dérivés de 2-aminopyrazine-5-carboxamide, leur préparation et leur application en thérapeutique.
DE4426346A1 (de) * 1994-07-25 1996-02-01 Basf Ag Herbizide Pyrazinderivate
CA2241933C (en) 1997-07-03 2008-10-07 Lonza Ag Process for preparing alkoxypyrazine derivatives
DE60237528D1 (de) 2001-09-14 2010-10-14 High Point Pharmaceuticals Llc Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
US7286880B2 (en) * 2003-10-02 2007-10-23 Medtronic, Inc. System and method for transcutaneous energy transfer achieving high efficiency
CN113924294A (zh) * 2019-05-29 2022-01-11 先正达农作物保护股份公司 杀微生物衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3544568A (en) * 1969-03-18 1970-12-01 Merck & Co Inc 3-amino-5,6-substituted pyrazinamides

Also Published As

Publication number Publication date
DK673074A (xx) 1975-09-08
YU347074A (en) 1982-06-18
FR2257293B1 (xx) 1980-02-08
SE7416137L (xx) 1975-07-17
AT340437B (de) 1977-12-12
YU36934B (en) 1984-08-31
CA1050540A (en) 1979-03-13
NL7417060A (nl) 1975-07-18
GB1484049A (en) 1977-08-24
DK139846C (xx) 1979-10-08
ATA1028874A (de) 1977-04-15
ES433462A1 (es) 1976-12-16
FR2257293A1 (xx) 1975-08-08
DE2461802C2 (de) 1985-01-03
AU7664974A (en) 1976-06-24
DK139846B (da) 1979-04-30
DE2461802A1 (de) 1975-07-17
US4041032A (en) 1977-08-09

Similar Documents

Publication Publication Date Title
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE433222B (sv) Sett att framstella modifierad polysackarid
SE419645B (sv) Sett att framstella 3-amino-indazolkarbonylsyra derivat
SE7600277L (sv) Sett att framstella sampolymerisatpulver
SE7606280L (sv) Sett att framstella etrar
SE7506743L (sv) Sett att framstella bispidin- och bispidonderivat
SE425244B (sv) Sett att framstella 4-hydroxi-3-kinolin-karboxamidderivat
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE425312B (sv) Sett att framstella morfolinderivat
SE425850B (sv) Sett att framstella abietamidderivat.
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE7810147L (sv) Sett att framstella cefalosporansyraderivat
SE427930B (sv) Sett att atervinna organotennhalogenider
SE428471B (sv) Sett att framstella imidazolderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7416137-3

Effective date: 19891128

Format of ref document f/p: F